Document is current
Any future updates will be listed below
-
Authors
Ceuppens, Hannelore https://orcid.org/0000-0003-0187-4204
Pombo Antunes, Ana Rita
Navarro, Laurent
Ertveldt, Thomas
Berdal, Marion
Nagachinta, Surasa
De Ridder, Kirsten
Lahoutte, Tony
Keyaerts, Marleen
Devoogdt, Nick
Goyvaerts, Cleo
D’Huyvetter, Matthias
Breckpot, Karine
-
Funding
Funding for this research was provided by:
Innoviris (BRGRD44)
Vrije Universiteit Brussel (SRP48)
Kom op tegen Kanker (ANI304, ANI368)
Stichting Wetenschappelijk Onderzoek Oogziekenhuis (G041721N)
Fonds Wetenschappelijk Onderzoek (1S06622N, 1801619N, 12H3619N)
Bijzonder Onderzoeksfonds UGent (iBOF/23/043)
Eutopia Foundation (OZR3808BOF)
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 1 September 2024
First Online: 6 September 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethics committee for use of laboratory animals of the Vrije Universiteit Brussel (ethical dossier numbers: 22-272-12, 22-272-19, 23-214-12).
: K.B., N.D., M.D., M.K. and T.L have patents on using sdAbs for imaging and therapy. T.L., N.D. and M.K. have ownership in AbScint. M.K. received research funding from Precirix. N.D. and M.D are respectively consultant and employee for and hold ownership in Precirix. A.R.P.A., L.N., M.B. and S.N. are employees of Precirix. M.K. is an editor of EJNMMI.
